2024-03-15 13:25:53 ET
More on J&J, Legend Biotech, etc.
- Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)
- Johnson & Johnson (JNJ) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Johnson & Johnson (JNJ) Leerink Partners Global Biopharma Conference (Transcript)
- J&J, Bristol Myers slip as FDA comments on CAR-T drugs ahead of AdCom
- J&J submits sBLA for Tremfya for ulcerative colitis
Read the full article on Seeking Alpha
For further details see:
Johnson & Johnson wins FDA AdCom backing for Carvykti label expansion